Bpifrance

Activity from announced rounds

Activity in this selectionFrance · Oct 12, 2026 · Jan 1, 2026

Bpifrance is France’s public investment bank, financing businesses through equity, loans and guarantees and supporting innovation and international expansion.

Its equity activity includes venture capital, growth investment and investments in other funds. Innovation financing can also support research, development and bringing a product to market, so founders may have financing options beyond a conventional equity round.

The appropriate route depends on the project and stage: research funding, a guarantee for borrowing, direct investment and export support serve different needs. Its bank-for-entrepreneurs model connects those instruments with programmes for developing a French business.

Sources
Rounds participated in
15
Confirmed lead rounds
0
8 roles undisclosed
New companies
15
First participation on record · 0 follow-on
Funding in participating rounds
$1.8B
13 disclosed · full round size, not this investor’s share

By stage

Series A5
Seed4
Series B2
Undisclosed2
Pre-seed1
1 more
Series C+1

By primary sector

Biotech4
AI3
Cybersecurity2
Foodtech2
Edtech1
3 more
Enterprise software1
Fintech1
Hardware1

By country

France15

Rounds

15 in this selection
Edonia

French foodtech company making protein-rich ingredients from spirulina.

€15MSeries A financing package including non-dilutive and bank funding
Participant
Edison IA

Edison IA helps small and mid-sized businesses put AI to work through executive training, process diagnosis and deployed business agents.

€1MSeed
Participant
Hackuity

Hackuity consolidates vulnerability findings from security tools and helps organisations prioritise remediation against their actual exposure.

$19MSeries B
Participant
Delos

Delos sells autonomous AI workers that take on defined business tasks through a company’s messaging and software tools.

€10MSeries A
Participant
Kaiko

Market data, analytics and infrastructure that help financial institutions price, trade and manage risk in digital assets.

$57MSeries B-2 extension
Participant
Ed.ai

AI assessment software that helps teachers turn exam papers into editable grading rubrics, review assisted marking and target students’ learning gaps.

€5MSeed
Participant
One Biosciences

Single-cell tumour profiling for oncology teams and pharma and biotech partners, turning routine biopsy samples into clinical insights for treatment selection and drug development.

€3.3Mi-Démo 5 grant (France 2030)
Participant
Brenus Pharma

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

€11MSeries A
Role not disclosed
Lys Therapeutics

Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke

Role not disclosed
Quobly

Develops silicon qubits for dense integration and compatibility with industrial fabrication standards

€115MSeries A
Role not disclosed
Omniscient

Provides AI-driven decision intelligence platform for boards and senior executives

$4.1MPre-Seed
Role not disclosed
Verley

Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers

€32MSeries A
Role not disclosed
GitGuardian

Provides a non-human identity security platform to detect and remediate leaked secrets in code

$50MSeries C
Role not disclosed
Mistral AI

Mistral AI develops AI models and computing infrastructure for enterprise and public-sector use.

€1.2BStrategic
Role not disclosed
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed